National Cancer Institute; Notice of Meeting, 3243 [2010-993]
Download as PDF
<![CDATA[
Federal Register / Vol. 75, No. 12 / Wednesday, January 20, 2010 / Notices
Information is also available on the
Institute’s/Center’s home page:
deainfo.nci.nih.gov/advisory/bsa.htm, where
an agenda and any additional information for
the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: January 14, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2010–992 Filed 1–19–10; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Meeting
pwalker on DSK8KYBLC1PROD with NOTICES
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
National Cancer Institute Board of
Scientific Advisors.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Name of Committee: National Cancer
Institute Board of Scientific Advisors.
Date: March 8–9, 2010.
Time: March 8, 2010, 8 a.m. to 6 p.m.
Agenda: Director’s Report: Ongoing and
New Business; Reports of Program Group(s);
and Budget Presentations; Reports of Special
Initiatives; RFA and RFP Concept Reviews;
and Scientific Presentations.
Place: National Institutes of Health,
Building 31, 31 Center Drive, 6th Floor, Conf.
Room 10, Bethesda, MD 20892.
Time: March 9, 2010, 8:30 a.m. to 12 p.m.
Agenda: Reports of Special Initiatives; RFA
and RFP Concept Reviews; and Scientific
Presentations.
Place: National Institutes of Health,
Building 31, 31 Center Drive, 6th Floor, Conf.
Room 10, Bethesda, MD 20892.
Contact Person: Paulette S. Gray, PhD,
Executive Secretary, Director, Division of
Extramural Activities, National Cancer
Institute, National Institutes of Health, 6116
Executive Boulevard, 8th Floor, Rm. 8001,
Bethesda, MD 20892, 301–496–5147,
grayp@mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
VerDate Nov<24>2008
16:06 Jan 19, 2010
Jkt 220001
Dated: January 13, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2010–993 Filed 1–19–10; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
NIH State-of-the-Science Conference:
Preventing Alzheimer’s Disease and
Cognitive Decline; Notice
Notice is hereby given by the National
Institutes of Health (NIH) of the ‘‘NIH
State-of-the-Science Conference:
Preventing Alzheimer’s Disease and
Cognitive Decline’’ to be held April 26–
28, 2010, in the NIH Natcher Conference
Center, 45 Center Drive, Bethesda,
Maryland 20892. The conference will
begin at 8:30 a.m. on April 26 and 27
and at 9 a.m. on April 28, and it will
be open to the public.
For many older adults, cognitive
health and performance remain stable
over the course of their lifetime, with
only a gradual and slight decline in
short-term memory and reaction times.
But for others, this normal, age-related
decline in cognitive function progresses
into a more serious state of cognitive
impairment or into various forms of
dementia, including Alzheimer’s
disease. Such loss of cognitive
function—the ability to think, learn,
remember, and reason—substantially
interferes with everyday function. As
researchers continue to explore changes
in the brain that take place possibly
decades before cognitive decline and
dementia symptoms appear, they also
hope to discover more about the
relationship between normal age-related
cognitive decline and the development
of cognitive impairment or Alzheimer’s
disease.
Alzheimer’s disease was first
described in 1906, when German
psychiatrist and neuropathologist Alois
Alzheimer observed the hallmarks of the
PO 00000
Frm 00051
Fmt 4703
Sfmt 4703
3243
disease in the brain of a female patient
who had experienced memory loss,
language problems, and unpredictable
behavior: abnormal clumps of protein
(now called beta-amyloid plaques) and
tangled bundles of protein fibers (now
called neurofibrillary tangles). Today,
an estimated 2.5 to 4.5 million
Americans are living with Alzheimer’s,
the most common form of dementia, and
those numbers are expected to grow
with the aging of the baby boomer
population. Age is the strongest known
risk factor for Alzheimer’s, with most
people diagnosed with the late-onset
form of the disease over age 60. An
early-onset, familial form also occurs,
but is very rare. The time from diagnosis
to death with Alzheimer’s ranges from
as little as 3 years to 10 or more,
depending on the person’s age, sex, and
the presence of other health problems.
In addition to investigating the causes
and potential treatments for Alzheimer’s
and other dementias, researchers are
focused on finding ways to prevent
cognitive decline. Many preventive
measures for cognitive decline and for
preventing Alzheimer’s—mental
stimulation, exercise, and a variety of
dietary supplements—have been
suggested, but their value in delaying
the onset and/or reducing the severity of
decline or disease is unclear. Questions
also remain as to how the presence of
certain conditions, such as high
cholesterol, high blood pressure, and
diabetes, influence an individual’s risk
of cognitive decline and Alzheimer’s
disease.
To examine these important questions
about Alzheimer’s and cognitive decline
in older people, the National Institute
on Aging and the Office of Medical
Applications of Research of the NIH will
convene a State-of-the-Science
Conference from April 26 to 28, 2010, to
assess the available scientific evidence
related to the following questions:
• What factors are associated with the
reduction of risk of Alzheimer’s disease?
• What factors are associated with the
reduction of risk of cognitive decline in
older adults?
• What are the relationships between
the factors that affect Alzheimer’s
disease and the factors that affect
cognitive decline?
• What are the therapeutic and
adverse effects of interventions to delay
the onset of Alzheimer’s disease?
• What are the therapeutic and
adverse effects of interventions to
improve or maintain cognitive ability or
preserve cognitive function? Are there
different outcomes in identifiable
subgroups?
• If recommendations for
interventions cannot be made currently,
E:\FR\FM\20JAN1.SGM
20JAN1
]]>Agencies
[Federal Register Volume 75, Number 12 (Wednesday, January 20, 2010)]
[Notices]
[Page 3243]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-993]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Meeting
Pursuant to section 10(a) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of a meeting of the
National Cancer Institute Board of Scientific Advisors.
The meeting will be open to the public, with attendance limited to
space available. Individuals who plan to attend and need special
assistance, such as sign language interpretation or other reasonable
accommodations, should notify the Contact Person listed below in
advance of the meeting.
Name of Committee: National Cancer Institute Board of Scientific
Advisors.
Date: March 8-9, 2010.
Time: March 8, 2010, 8 a.m. to 6 p.m.
Agenda: Director's Report: Ongoing and New Business; Reports of
Program Group(s); and Budget Presentations; Reports of Special
Initiatives; RFA and RFP Concept Reviews; and Scientific
Presentations.
Place: National Institutes of Health, Building 31, 31 Center
Drive, 6th Floor, Conf. Room 10, Bethesda, MD 20892.
Time: March 9, 2010, 8:30 a.m. to 12 p.m.
Agenda: Reports of Special Initiatives; RFA and RFP Concept
Reviews; and Scientific Presentations.
Place: National Institutes of Health, Building 31, 31 Center
Drive, 6th Floor, Conf. Room 10, Bethesda, MD 20892.
Contact Person: Paulette S. Gray, PhD, Executive Secretary,
Director, Division of Extramural Activities, National Cancer
Institute, National Institutes of Health, 6116 Executive Boulevard,
8th Floor, Rm. 8001, Bethesda, MD 20892, 301-496-5147,
grayp@mail.nih.gov.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has instituted stringent
procedures for entrance onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles will be inspected
before being allowed on campus. Visitors will be asked to show one
form of identification (for example, a government-issued photo ID,
driver's license, or passport) and to state the purpose of their
visit.
Information is also available on the Institute's/Center's home
page: deainfo.nci.nih.gov/advisory/bsa.htm, where an agenda and any
additional information for the meeting will be posted when
available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: January 13, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2010-993 Filed 1-19-10; 8:45 am]
BILLING CODE 4140-01-P
